Amlodipine Besylate Price Trend and Forecast 2026-2027

Market Overview

Feedstock Product: Calcium Channel Blocker Precursors

Amlodipine besylate is a calcium channel blocker used to treat high blood pressure and angina pectoris, representing one of the most widely prescribed antihypertensive medications globally. Major producers include Pfizer, Macleods Pharmaceuticals, Torrent Pharmaceuticals, and several Indian and Chinese manufacturers. Pricing of amlodipine besylate is driven by raw material costs, regulatory compliance requirements, manufacturing capacity, pharmaceutical demand cycles, and competitive dynamics in the branded and generic segments. Demand surges during winter months due to higher hypertension incidence, while supply chains remain sensitive to regulatory changes and patent expirations.

Geopolitical Impact of Iran, US, and Israel War on Amlodipine Besylate

The ongoing geopolitical conflict that began February 28, 2026, has created significant supply chain disruptions affecting amlodipine besylate production and pricing. Brent crude surged 55 percent in March 2026, climbing from USD 72.48 to USD 112.57 per barrel, directly impacting petrochemical feedstocks used in synthesis. The Strait of Hormuz, which handles approximately 30 percent of global seaborne oil, became effectively closed from March 4, 2026, forcing alternative shipping routes and raising logistics costs. LNG spot prices in Asia rose over 140 percent, increasing energy costs for manufacturing facilities throughout the pharmaceutical supply chain. QatarEnergy declared force majeure on all exports, further constraining energy availability.

Chemical manufacturers worldwide imposed surcharges up to 30 percent to offset these increased costs. Oil production from Kuwait, Iraq, Saudi Arabia, and UAE dropped 6.7 million barrels per day by March 10, creating severe energy security concerns. The International Energy Agency called this the greatest global energy security challenge in history. For amlodipine besylate specifically, these developments raise manufacturing costs in energy-intensive synthesis steps, increase shipping expenses from India and China to North America and Europe, and push up costs for supporting chemicals and packaging materials. Pharmaceutical manufacturers have absorbed some costs but are passing others to healthcare systems and patients, with price increases of 8 to 12 percent becoming common by late March 2026.

For the Quarter Ending March 2026

Amlodipine Besylate Prices in North America

• USA pricing reached USD 76,440/MT in Q2 2025 but climbed to approximately USD 82,100/MT by March 2026 due to geopolitical disruptions
• North American pharmaceutical manufacturers faced elevated raw material costs and energy surcharges of 8 to 12 percent imposed by suppliers
• Demand remained steady from hospital procurement and retail pharmacy channels despite economic uncertainty
• Logistics costs from Asia increased 18 to 22 percent due to rerouting around the Strait of Hormuz
• Regulatory compliance costs rose modestly as manufacturers implemented supply chain resilience measures
• Inventory building by major distributors in February 2026 temporarily supported pricing firmness

Why did the price of Amlodipine Besylate change in March 2026 in North America?

• Geopolitical conflict and closed Strait of Hormuz forced longer shipping routes, raising freight costs by 18 to 22 percent and extending delivery times to 45 to 50 days from typical 25 days
• Energy surcharges of 8 to 12 percent imposed by chemical suppliers translated directly into higher manufacturing costs for active pharmaceutical ingredients
• Brent crude reaching USD 112.57 per barrel in March 2026 increased feedstock and energy costs for supporting chemicals used in amlodipine besylate synthesis

Amlodipine Besylate Prices in APAC

• China manufacturing output advanced 6.6 percent year-on-year in January-February 2026, providing moderate demand support for active ingredients
• India remained the largest producer, with prices climbing from USD 73,500/MT in Q4 2025 to approximately USD 79,200/MT by March 2026
• Southeast Asian manufacturing PMI showed 52.1 in February 2026, the highest since December 2020, indicating solid production activity
• Official NBS PMI in China stood at 49.0 in February 2026, signaling contraction in manufacturing that moderated demand growth
• Asian LNG spot prices surged over 140 percent, increasing electricity and gas costs for pharmaceutical manufacturers across the region

Why did the price of Amlodipine Besylate change in March 2026 in APAC?

• Indian manufacturers faced elevated raw material costs and implemented 6 to 10 percent surcharges as energy costs climbed following the Middle East disruption
• Chinese pharmaceutical producers, though less dependent on imported energy, experienced supply chain delays and raised prices to secure feedstock availability
• Export demand from Europe and North America remained strong despite higher logistics costs, supporting pricing firmness among Asian suppliers

Amlodipine Besylate Prices in Europe

• Germany manufacturing PMI revised to 52.2 in March 2026, marking the strongest reading since May 2022 and signaling robust demand
• Eurozone manufacturing PMI stood at 51.6 in March 2026, the strongest in 45 months, supporting pharmaceutical ingredient demand
• Brent crude passed USD 120 per barrel in late March 2026, driving up energy and feedstock costs across the continent
• Vessel rerouting from the Closed Strait of Hormuz increased freight rates from Asia by 20 to 25 percent, raising import costs for amlodipine besylate precursors
• EU regulatory pressures regarding supply chain transparency added compliance costs estimated at 2 to 3 percent of manufacturing expenses

Why did the price of Amlodipine Besylate change in March 2026 in Europe?

• Strong manufacturing PMI signals and solid healthcare demand supported pricing resilience, allowing producers to pass through cost increases
• Longer shipping routes and vessel rerouting increased landed costs for imports from Asia, raising retail prices 10 to 14 percent
• Energy cost spikes from geopolitical disruption prompted surcharges across the European pharmaceutical supply chain

For the Quarter Ending December 2025

APAC

• India prices averaged USD 74,800/MT in December 2025, with steady demand from domestic and export markets
• China prices stood at USD 72,300/MT, reflecting competitive pressures and lower costs than developed markets
• Southeast Asian demand remained stable with prices near USD 70,200/MT as regional healthcare systems maintained procurement schedules

Why did the price of Amlodipine Besylate change in December 2025 in APAC?

• Year-end inventory restocking by wholesalers and hospital systems supported steady pricing without significant upward movement
• Competitive dynamics among Indian producers limited price increases despite global demand strength
• Chinese manufacturing capacity remained abundant, constraining margins and pricing power

Europe

• Germany prices reached USD 75,900/MT in December 2025, reflecting stable demand from the healthcare system
• France and Spain averaged USD 74,100/MT, showing moderate demand from pharmacy networks
• EU prices generally tracked slightly above Asian markets due to regulatory overhead and higher labor costs

Why did the price of Amlodipine Besylate change in December 2025 in Europe?

• Healthcare system budgets were finalized, locking in procurement at established pricing levels
• Winter seasonality drove slightly higher demand for antihypertensive medications among aging European populations
• Oil prices near USD 85-90 per barrel remained manageable without creating supply shocks

North America

• USA prices averaged USD 76,440/MT in December 2025, with stable demand from retail and hospital channels
• Canada prices tracked slightly above USA levels at approximately USD 77,300/MT due to import tariffs
• Mexico prices remained lower at USD 71,500/MT, reflecting regional manufacturing cost advantages

Why did the price of Amlodipine Besylate change in December 2025 in North America?

• Generic competition among multiple suppliers kept price increases modest despite global supply tightness
• Year-end pharmaceutical inventory builds by major wholesalers supported volume demand and pricing stability
• Healthcare system budgets remained flush from year-end allocations, supporting procurement at established prices

For the Quarter Ending September 2025

North America

• USA prices reached USD 71,465/MT in September 2025, showing modest quarterly decline from summer levels
• Supply of active ingredients from Indian manufacturers remained adequate with competitive bidding keeping prices in check
• Summer holiday periods in Europe and Asia reduced shipping activity, allowing inventory accumulation in North American distribution centers

APAC

• China prices averaged USD 69,800/MT in Q3 2025, declining on weaker domestic demand and export market softness
• India prices held at USD 73,200/MT despite competitive pressure, supported by strong export orders from developed markets
• Regional manufacturing PMI data showed 52.1, indicating sustained production activity across the region

Europe

• German manufacturing centers reported prices near USD 74,500/MT in September 2025, steady from prior quarter
• Healthcare system demand remained balanced across the continent with moderate seasonal variation
• Logistics costs from Asia normalized as shipping capacity recovered post-summer congestion

For the Quarter Ending June 2025

APAC

• India prices averaged USD 75,100/MT in June 2025, supported by strong export demand and limited production additions
• China faced competitive pressures with prices near USD 68,400/MT as manufacturers sought market share
• Regional demand remained robust from both domestic healthcare systems and export-oriented producers

North America

• USA prices reached USD 76,440/MT in Q2 2025, the benchmark for the first half of 2026
• Healthcare system procurement remained steady with year-round patterns supporting stable pricing
• Summer heat increased demand for blood pressure medications, providing modest support

Europe

• German pharmaceutical hub reported prices near USD 74,200/MT as regional demand held steady
• Manufacturing activity remained at pre-pandemic levels with adequate supply chains
• Regulatory requirements for amlodipine besylate remained unchanged, with no supply disruptions reported

For the Quarter Ending March 2025

North America

Amlodipine besylate prices in North America averaged USD 74,800/MT during Q1 2025, reflecting stable demand from the retail pharmaceutical sector and hospital procurement channels. Winter seasonality drove higher volumes as cardiovascular disease incidence peaks during cold months. Domestic manufacturers maintained pricing discipline despite incoming shipments from Indian and Chinese competitors, with most suppliers recognizing mutual benefit in price stability over volume wars.

APAC

Asian producers faced moderate competition in Q1 2025, with Indian manufacturers averaging USD 72,400/MT and Chinese producers slightly below at USD 67,900/MT. Strong export demand to developed markets provided volume support, keeping capacity utilization near 82 percent. Regional demand from domestic markets grew steadily as aging populations drove hypertension medication consumption across emerging economies.

Europe

European pharmaceutical systems maintained steady procurement of amlodipine besylate in Q1 2025, with prices averaging USD 73,600/MT across major markets. German manufacturing hubs reported adequate supply with minimal disruption. Regulatory compliance costs remained moderate, and no significant supply chain issues emerged during this period.

How We Can Help

Expert Market Research: Your Source for Real-Time Amlodipine Besylate Price Intelligence

Our team provides real-time pricing data, comprehensive market analysis, and procurement advisory services across 450-plus pharmaceutical ingredients and chemicals. We track regional price movements, supply chain dynamics, regulatory impacts, and geopolitical risks to help pharmaceutical manufacturers, wholesalers, and hospital systems optimize purchasing strategies. Access our market reports, forecasts, and pricing databases to make informed sourcing decisions for amlodipine besylate and related active pharmaceutical ingredients.